From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...
HONOLULU (HawaiiNewsNow) - A Children’s Miracle Network champion was named at a ceremony held Wednesday. Four-year-old Seeley Borges was named Hawaii’s 2026 Children’s Miracle Network Champion for ...
Acute Myeloid Leukemia is the most common acute leukemia in adults affecting 2-6 adults per 100,000k globally. -With relapse rates as high as 50%, routine measurable residual disease (MRD) ...
Add Yahoo as a preferred source to see more of our stories on Google. Tula Hunt, 6, has been diagnosed with Acute Myeloid Leukaemia (AML), which affects around 100 children a year in the UK (Image: ...
New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.
Children diagnosed with aggressive cancers could benefit from a pioneering project supported by Southampton researchers to create new treatments.
Selected as a C-Further program with up to $1.1 million in non-dilutive, aggregate payments to advance IND-enabling development, with potential for meaningful double-digit downstream commercial ...
Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the response to treatment of acute ...
Patients undergoing intensive chemotherapy for acute myeloid leukemia are routinely treated with multiple antibiotics to prevent infection, a practice that new research from Texas A&M University shows ...
Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...
Asianet Newsable on MSN
SLS stock falls premarket: CEO touts GPS leukemia strategy, but investors stay cautious as AML trial nears readout
The CEO said Sellas is pursuing a “security force” immunotherapy strategy that trains immune cells to recognize cancer even as tumors evolve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results